Some previous studies classified somatotroph tumors with hyperprolactinemia as GH and PRL cosecreting tumors (10, 30), whereas other authors considered cosecreting tumors when tumors stained positive for both GH and PRL by IHC (31–33). This evidence concerns the gene PRL and hyperprolactinemia.